A Study of Two Iodinated Contrast Agents in Renally Impaired Patients Undergoing Cardiac Angiography
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to compare the incidence of contrast induced nephrotoxicity
following the administration of Isovue or Visipaque in patients with moderate to severe renal
insufficiency undergoing cardiac angiography. Serum creatinine will be measured before and up
to 48-72 hours after the administration of the contrast agent to evaluate renal function.